2. Drug-Target Characterization Flashcards
why can we not determine affinity of a drug in a cell culture assay?
too much stuff in cell –> not isolated system
why do we express protein in bacteria? how do we express protein in bacteria (3 steps)?
to allow for protein purification
- cDNA encoding for protein of interest is ligated into a plasmid for bacterial expression
- harvest bacteria
- lyse cells then extract protein
what is the main way to extract protein?
chromatography
what are the 2 phases of chromatography?
- stationary phase –> inert or active solid phase
- mobile phase –> bacterial lysate and buffer
what is the benefit for chromatography that is automated?
allows for a standardized method so purification is always the same
what are 2 types of chromatography?
- size exclusion chromatography
- affinity chromatography
why are beads cross-linked in chromatography?
so they don’t react with anything
what is unique about beads in size exclusion chromatography?
they have pores
describe size exclusion chromatography
buffer with bacterial lysate will constantly flow thru
- LARGE molecules will not enter the pores and are eluted first
- SMALL molecules will enter the pores and will be eluted last –> will have to cross bigger volume to eventually get eluted
in general, how are proteins separated in affinity chromatography?
separated by biophysical traits
what are 4 examples of ways we can purify proteins with affinity chromatography?
- hydrophobicity
- ligands
- metals (some proteins bind metal)
- protein tags
what are 3 examples of ligands that can be used in affinity chromatography?
- lectins
- protein A/G
- collagen
how do we purify using protein tags?
doesn’t purify by endogenous property –> protein is tagged with something that can bind to another molecule attached to the beads
what are 4 examples of protein tags used in affinity chromatography?
- histidine binds Ni-NTA-beads
- GST binds glutathione-sepharose/agarose-beads
- MBP binds amylose resin-beads
- myc, flag, V5 binds antibodies against the tags
what is it called when we use antibodies in affinity chromatography?
immunoprecipitation
what is the general idea for the radioligand competition assay?
drug is radiolabeled (1 atom replaced by isotope) and added to purified protein target
filter this solution –> radioligand bound to protein is too big to cross the filter so it will stick to the filter paper and can measure radioactivity
describe the 4 steps of the radioligand competition assay
- start with only radioligand –> radioligand will saturate all purified protein target
- then add normal ligand in increasing concentrations
- normal ligand will compete and replace the radioligand so radioactivity on the filter paper will decrease
- continue until no more radioligand
how do we analyze the radioligand competition assay? describe the graph
what value does the curve give us?
look at changes in inhibition curves
Y = amount of radioligand bound
X = concentration of normal ligand
curve starts with high radioactivity (binding site saturated with radioligand), then decreases with increasing doses of normal ligand
gives us IC50 –> concentration of normal ligand that displaces 50% of the radioactive ligand –> tells us affinity and proves specificity
what is an alternate way of using the radioligand competition assay? explain
can see if 2 different drugs bind at the same or different binding sites
1 drug is radiolabeled, 1 drug is not
- if both drugs bind at the same site –> reduced radioactivity bc competition
- if each drug binds at a different site –> radioactivity is maintained bc no competition
describe how elution is also a competition
if we have a drug bound to a GST-tagged protein for example: it will bind glutathione-beads
if we add free glutathione, it will compete with the beads to bind to the protein, allowing us to elute the protein
describe the instrument used in surface plasmon resonance
instrument has flow chamber that sits above the gold part of a plastic chip –> the flow chamber has a volume of 2nL
why is the volume in the flow chamber important?
its only 2nL so it’s helpful when you have very little drug
describe the gold chip in surface plasmon resonance
functional groups (ex. disfulfide) stick off the gold part, allowing protein of interest to be COVALENTLY bound and immobilized on the surface
what happens to high affinity drugs in buffer solution flows thru the chamber?
high affinity drugs have greater intermolecular forces with the receptor, so they will bind
what happens to low affinity drugs in buffer solution flows thru the chamber?
low affinity drugs have less intermolecular forces with the receptor so they will bind less well
what is the principle of surface plasmon resonance? (describe the light)
3 steps
- infrared light strikes the gold at an angle of total reflection (fully reflected out)
- gold layer becomes activated via EVANESCENT WAVE and some energy from the light is absorbed
- decrease in light intensity causes a shadow at a certain angle
what are the 4 steps of surface plasmon resonance?
- drug flows over gold surface and binds to protein
- this changes the mass of what is bound to the gold layer
- the evanescent wave depends on the mass of what’s on the gold surface so the change in mass changes the angle of the shadow
- the angle change can be measured and plotted using a sensorgram
describe the sensorgram curve (3 time points)
t=1: buffer with drug flows thru
t=2: association curve as drug binds to protein, changing the shadow angle until equilibrium
t=3: stop buffer flow causing dissociation curve
why can drugs associate AND dissociate?
binding is not permanent!!!!
what 4 things does SPR let us measure?
1/2. association and dissociation rates over time
3/4. association and dissociation equilibrium constants
what is Ka? what does low kA mean? what is the equation and units?
Ka = association tendency
low Ka = low affinity